Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Vvd-214
2. 3026500-20-6
3. Vvd-133214
4. Ro7589831
5. Vvd214
6. Gtpl13353
7. Ex-a8890
8. Nsc854461
9. Rg6457
10. Vvd133214
11. Nsc-854461
12. Rg-6457
13. Hy-158116
14. Cs-1047739
15. Ro-7589831
16. H38320
17. (s,e)-n-(1-cyclopropyl-3-(methylsulfonyl)allyl)-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide
| Molecular Weight | 437.5 g/mol |
|---|---|
| Molecular Formula | C20H21F2N3O4S |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 107 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 731 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
68
PharmaCompass offers a list of VVD-214 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right VVD-214 manufacturer or VVD-214 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred VVD-214 manufacturer or VVD-214 supplier.
PharmaCompass also assists you with knowing the VVD-214 API Price utilized in the formulation of products. VVD-214 API Price is not always fixed or binding as the VVD-214 Price is obtained through a variety of data sources. The VVD-214 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A VVD-214 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of VVD-214, including repackagers and relabelers. The FDA regulates VVD-214 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. VVD-214 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A VVD-214 supplier is an individual or a company that provides VVD-214 active pharmaceutical ingredient (API) or VVD-214 finished formulations upon request. The VVD-214 suppliers may include VVD-214 API manufacturers, exporters, distributors and traders.
VVD-214 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of VVD-214 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right VVD-214 GMP manufacturer or VVD-214 GMP API supplier for your needs.
A VVD-214 CoA (Certificate of Analysis) is a formal document that attests to VVD-214's compliance with VVD-214 specifications and serves as a tool for batch-level quality control.
VVD-214 CoA mostly includes findings from lab analyses of a specific batch. For each VVD-214 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
VVD-214 may be tested according to a variety of international standards, such as European Pharmacopoeia (VVD-214 EP), VVD-214 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (VVD-214 USP).
